Kunming Longjin Pharmaceutical Co., Ltd. announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 164.384 million compared to CNY 188.252 million a year ago. Operating loss was CNY 1.581 million compared to operating Income of CNY 3.533 million a year ago. Net income was CNY 2.284 million compared to CNY 1.549 million a year ago. Basic earnings per share from continuing operations was CNY 0.0057 compared to CNY 0.0039 a year ago.